Muscle Spasticity Market is Predicted to Grow at a Remarkable CAGR During the Forecast Period (2022-32), Analyzes DelveInsight | Key Companies – GW Pharma, Ipsen, Allergan, Merz Pharma, Revance

November 15 19:58 2022
Muscle Spasticity Market is Predicted to Grow at a Remarkable CAGR During the Forecast Period (2022-32), Analyzes DelveInsight | Key Companies - GW Pharma, Ipsen, Allergan, Merz Pharma, Revance
Delveinsight Business Research LLP
As per DelveInsight, the Muscle Spasticity therapeutics market is expected to transform in the coming years owing to the increased awareness of the unique histology that has allowed the development of drugs that are specific to Spasticity along with the expected launch of emerging therapies and active participation of the global pharma and biotech giants in the therapeutics segment.

DelveInsight’s “Muscle Spasticity Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Muscle Spasticity market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Muscle Spasticity market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Muscle Spasticity: An Overview

Spasticity is defined as a “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as intermittent or sustained involuntary activation of muscles. The region and the extent of impairment depending on the area of the brain or spinal cord that has been damaged. It can occur in the upper and lower limbs.

Spasticity may occur in many neurological conditions, including multiple sclerosis (MS), cerebral palsy (CP), spinal cord injury (SCI), stroke, and traumatic brain injury (TBI). The prevalence of common spasticity may range according to the causative factors. Spasticity can range from mild muscle stiffness to severe, painful, and uncontrollable muscle spasms. There are three types of spasticity, generalized, regional, and focal spasticity, based on affected body size. 

Muscle Spasticity Market Key Facts

  • According to NICE, Cerebral palsy is the most common condition associated with spasticity in children and young people. The incidence of cerebral palsy is unknown, but its prevalence in the UK is 186 per 100,000 population, with a total of 110,000 people affected.

  • According to MyChild at CerebralPalsy Organization, Spastic Cerebral Palsy is most common, making up 61–76.9% of all Cerebral Palsy cases. John Hopkins Medicine also mentioned that Spasticity affects over 12 million people worldwide, including approximately 80% of people with cerebral palsy and multiple sclerosis.

  • As per DelveInsight, the dynamics of the Muscle Spasticity market are anticipated to change in the coming years owing to the rise in healthcare spending worldwide and the launch of emerging therapies. 

  • Globally, several key players, such as GW Pharmaceuticals, Revance Therapeutics, and several others, are actively involved in developing therapies for Spasticity.

Muscle Spasticity Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Muscle Spasticity market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Muscle Spasticity market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.

Muscle Spasticity Epidemiology Assessment 

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders. 

The Report Covers the Muscle Spasticity Epidemiology Segmented by – 

  • Total prevalent cases of Muscle Spasticity

  • Total prevalent cases of Muscle Spasticity associated with common conditions

  • Diagnosed and treatable cases of Muscle Spasticity

Muscle Spasticity Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Muscle Spasticity market or expected to get launched during the study period. The analysis covers the Muscle Spasticity market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Muscle Spasticity Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How Muscle Spasticity Market Will Evolve by 2032 @

Some of the key companies in the Muscle Spasticity therapeutics market include:

  • GW Pharmaceuticals

  • Ipsen

  • Allergan

  • Merz Pharma

  • Revance Therapeutics

  • Janssen Pharmaceutical

  • Abide Therapeutics

And many more

Muscle Spasticity Therapies covered in the report include:

  • Arbaclofen ER

  • Nabiximols

  • DAXI

  • IPN10200

  • Lu AG06466

And many others

Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Muscle Spasticity Competitive Intelligence Analysis

4. Muscle Spasticity Market Overview at a Glance

5. Muscle Spasticity Disease Background and Overview

6. Muscle Spasticity Patient Journey

7. Muscle Spasticity Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Muscle Spasticity Treatment Algorithm, Current Treatment, and Medical Practices

9. Muscle Spasticity Unmet Needs

10. Key Endpoints of Muscle Spasticity Treatment

11. Muscle Spasticity Marketed Products

12. Muscle Spasticity Emerging Drugs and Latest Therapeutic Advances

13. Muscle Spasticity Seven Major Market Analysis

14. Attribute Analysis

15. Muscle Spasticity Market Outlook (In US, EU5, and Japan)

16. Muscle Spasticity Access and Reimbursement Overview

17. KOL Views on the Muscle Spasticity Market

18. Muscle Spasticity Market Drivers

19. Muscle Spasticity Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF to Explore the Key Offerings of the Report @

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Other Trending Healthcare Reports By DelveInsight

Muscle Spasticity Pipeline Insight

DelveInsight’s “Muscle Spasticity – Pipeline Insight, 2022,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. Moreover, it provides therapeutics assessment by product type, stage, route of administration, and molecule type.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States